Aug 2026· BMC Pediatrics· Vol 26· 0 citations· 14 references
Medicine
TL;DR
This study describes a 13-month-old Chinese boy who presented with global developmental delay, axial hypotonia, stereotypic hand-flapping movements, limited vocalization, and mild facial dysmorphism and identifies a novel de novo heterozygous deletion spanning exons 6-8 of SYT1, which was subsequently confirmed by quantitative PCR.
Abstract
Baker-Gordon syndrome (BGS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous pathogenic variants in SYT1, which encodes synaptotagmin-1, a key Ca2⁺ sensor for synaptic vesicle exocytosis. We describe a 13-month-old Chinese boy who presented with global developmental delay, axial hypotonia, stereotypic hand-flapping movements, limited vocalization, and mild facial dysmorphism. Brain magnetic resonance imaging revealed a simplified gyral pattern involving the frontal and parietal lobes. Trio-based whole-exome sequencing with read-depth copy-number variant (CNV) analysis identified a novel de novo heterozygous deletion spanning exons 6-8 of SYT1, which was subsequently confirmed by quantitative PCR. This study broadens the mutational spectrum of BGS and provides further evidence that intragenic multi-exon deletions affecting key functional domains may represent an alternative pathogenic mechanism in addition to the predominantly reported missense variants. Our findings also highlight the value of exon-level CNV analysis in the genetic diagnosis of neurodevelopmental disorders.
A 9-year-old male patient presenting with developmental delay, behavioral abnormalities, dysmorphic facial features, epilepsy, and congenital cardiac anomalies is reported, highlighting the importance of detailed neurological, electroencephalographic, cardiac, and genetic evaluation in patients with suspected DESSH.
Burak Yavuz, Soner Uzun, Ayhan Kütükçü et al.· American Journal of Medical...· 0 citations
The novel NR2F1 variant was classified as likely pathogenic according to ACMG guidelines, confirming the diagnosis of BBSOAS and the ARF3 variant, identified as a secondary finding of uncertain clinical significance, is unlikely to account for the patient's phenotype.
Sina Babaei, Haneieh Honarmand, M. Bonyadi et al.· Molecular Biology Reports· 0 citations
The allelic and phenotypic spectrum of MED25-related developmental disorder is broadened and the need for comprehensive evaluation across molecular, structural, and phenotypic pathways to elucidate variant signature in rare genetic disease models correctly is highlighted.
Camilo Andrés Yidi, S. Jiménez, Nataly Alejandra Solano et al.· Neurogenetics· 0 citations
This case adds longitudinal clinical, neuroimaging, ophthalmological, and neuropsychological data to the limited literature on patients carrying the p.Arg272His variant, supporting further investigation of genotype–phenotype relationships in ARSACS.
Vincenzo Sortino, A. Sapuppo, Anastasia Bernabini et al.· Neurogenetics· 0 citations
A Chinese patient presenting with classic hallmarks of MGORS7 alongside atypical clinical features, including hearing and visual impairments is reported, suggesting that growth hormone therapy may be beneficial for growth retardation in patients with MGORS7.
Ying Zhao, Yi-Yang Fu, Shu-Ying Zhang et al.· Frontiers in Genetics· 0 citations
BACKGROUND
The BORCS5 is an important and critical component of the BLOC-one-related complex (BORC), involved in kinesin-dependent anterograde lysosomal transport. Aberrations in the octameric protein complex encompass lethal neurological manifestations, such as arthrogryposis multiplex congenita, brain malformations a...
Arif Mahmood, A. Shah, Gohar Zaman et al.· International Journal of Dev...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.